PharmacyCodes



Methoxaminum [Inn-Latin] en es it fr

Methoxaminum [Inn-Latin] Brand names, Methoxaminum [Inn-Latin] Analogs

Methoxaminum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Methoxaminum [Inn-Latin] Chemical_Formula

C11H17NO3

Methoxaminum [Inn-Latin] RX_link

No information avaliable

Methoxaminum [Inn-Latin] fda sheet

Methoxaminum [Inn-Latin] msds (material safety sheet)

Methoxaminum_[Inn-Latin] MSDS

Methoxaminum [Inn-Latin] Synthesis Reference

No information avaliable

Methoxaminum [Inn-Latin] Molecular Weight

211.258 g/mol

Methoxaminum [Inn-Latin] Melting Point

No information avaliable

Methoxaminum [Inn-Latin] H2O Solubility

Soluble (185 g/L)

Methoxaminum [Inn-Latin] State

Solid

Methoxaminum [Inn-Latin] LogP

1.5

Methoxaminum [Inn-Latin] Dosage Forms

Liquid

Methoxaminum [Inn-Latin] Indication

Indicated for the treatment and management of hypotension.

Methoxaminum [Inn-Latin] Pharmacology

Methoxamine is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Methoxamine is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Methoxamine acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the heart's pumping action as well as constricting peripheral blood vessels.

Methoxaminum [Inn-Latin] Absorption

No information avaliable

Methoxaminum [Inn-Latin] side effects and Toxicity

No information avaliable

Methoxaminum [Inn-Latin] Patient Information

No information avaliable

Methoxaminum [Inn-Latin] Organisms Affected

Humans and other mammals